Disruptor SeriesSM
A quarterly insight and event series providing distinct perspectives on critical issues facing the capital markets
Upcoming Webcast
Healthcare Evolution: Past, Present and Future—
Advancing Patient Care in an Era of Accelerating Innovation
February 19, 2025 | 1PM ET
Healthcare is undergoing a profound transformation driven by groundbreaking advancements in technology, data and medicine. From predictive analytics and AI-enhanced diagnostics to precision treatments and robotics, these innovations are revolutionizing patient care.
Our latest AB Disruptor Series installment examines how the healthcare industry has evolved through three lenses: pre-diagnosis, diagnosis and treatment. We’ll highlight advances reshaping this “lifecycle of healthcare.” And we’ll offer a forward perspective on what these changes mean for all of us—as patients and investors.
What We'll Discuss
-
Pre-Diagnosis—On the Road from Reactive to Predictive Care:
From wearable tech to the ocean of information now available from standard fluid and tissue samples, big data and AI are enabling earlier risk detection and empowering individuals to take control of their health.
-
Diagnosis—More Precise, More Efficient:
Technologies such as advanced imaging, molecular diagnostics and AI-powered platforms are advancing disease detection, making diagnoses faster, more accurate and more accessible.
-
Treatment—Redefining Care with Innovation:
Genetic sequencing and targeted therapies are driving an evolution from “one size fits all” toward personalization. Robots and automation are advancing across the surgical spectrum, while regenerative medicine and nanotechnology could tackle once-untreatable conditions.
Presented By
Sign Up
Receive updates on our quarterly Disruptor Series events
Thank You
Thanks for your subscription to AB's Disruptors Series! Look forward to distinct perspectives on the critical issues facing the capital markets every quarter straight to your inbox.
More for You
Finding Growth in Mid Cap Value
AB Senior Research Analyst, Snezhana Otto, highlights potential growth opportunities in mid-cap value.
Finding Growth in Onshoring
AB CIO—US Small and Mid Cap Value Equities, James MacGregor, highlights the impact and potential benefit onshoring will have in the value universe.

Today’s investment world has been called a “factor zoo,” but value was arguably the first. With name-dropping candidates from Graham-Dodd to Fama-French to Warren Buffett, the original style, termed an investment “superfood,” earned that label by outpacing growth over the better part of a century.
Suggest a future topic
Past Topics
The information on this website is general communication and is educational in nature. It is for informational purposes only and is not designed to be a recommendation of any specific investment product, strategy or plan design or for any other purpose. Unless specified, examples used in the materials or online tools are completely hypothetical. By providing this information, neither AllianceBernstein nor its employees have the responsibility or authority to provide or have provided investment advice in a fiduciary capacity. Commentaries and opinions provided should not be construed as suggestions for taking or refraining from any course of action and should not be viewed as investment recommendations; they are provided as part of the general marketing and advertising activities of AllianceBernstein. Please contact your financial professional for investment advice tailored to your specific needs.